133 related articles for article (PubMed ID: 11869760)
1. Olanzapine versus haloperidol in schizoaffective disorder, bipolar type.
Tohen M; Zhang F; Keck PE; Feldman PD; Risser RC; Tran PV; Breier A
J Affect Disord; 2001 Dec; 67(1-3):133-40. PubMed ID: 11869760
[TBL] [Abstract][Full Text] [Related]
2. Olanzapine versus haloperidol treatment in first-episode psychosis.
Sanger TM; Lieberman JA; Tohen M; Grundy S; Beasley C; Tollefson GD
Am J Psychiatry; 1999 Jan; 156(1):79-87. PubMed ID: 9892301
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
Tollefson GD; Beasley CM; Tran PV; Street JS; Krueger JA; Tamura RN; Graffeo KA; Thieme ME
Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder.
Janicak PG; Keck PE; Davis JM; Kasckow JW; Tugrul K; Dowd SM; Strong J; Sharma RP; Strakowski SM
J Clin Psychopharmacol; 2001 Aug; 21(4):360-8. PubMed ID: 11476119
[TBL] [Abstract][Full Text] [Related]
5. Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol.
Tollefson GD; Sanger TM; Lu Y; Thieme ME
Arch Gen Psychiatry; 1998 Mar; 55(3):250-8. PubMed ID: 9510219
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: a randomized, double-blind, placebo- and haloperidol-controlled study.
Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
J Affect Disord; 2012 Feb; 136(3):476-84. PubMed ID: 22134043
[TBL] [Abstract][Full Text] [Related]
7. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
Citrome L; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; McEvoy J; Cooper TB; Chakos M; Lieberman JA
Psychiatr Serv; 2001 Nov; 52(11):1510-4. PubMed ID: 11684748
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; Chakos M; McEvoy JP
J Clin Psychiatry; 2002 Oct; 63(10):931-5. PubMed ID: 12416603
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine: a review of its use in the treatment of bipolar I disorder.
Bhana N; Perry CM
CNS Drugs; 2001; 15(11):871-904. PubMed ID: 11700151
[TBL] [Abstract][Full Text] [Related]
10. Olanzapine versus haloperidol in the treatment of schizoaffective disorder. Acute and long-term therapy.
Tran PV; Tollefson GD; Sanger TM; Lu Y; Berg PH; Beasley CM
Br J Psychiatry; 1999 Jan; 174():15-22. PubMed ID: 10211146
[TBL] [Abstract][Full Text] [Related]
11. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
[TBL] [Abstract][Full Text] [Related]
12. A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania.
Tohen M; Goldberg JF; Gonzalez-Pinto Arrillaga AM; Azorin JM; Vieta E; Hardy-Bayle MC; Lawson WB; Emsley RA; Zhang F; Baker RW; Risser RC; Namjoshi MA; Evans AR; Breier A
Arch Gen Psychiatry; 2003 Dec; 60(12):1218-26. PubMed ID: 14662554
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of early treatment response in antipsychotic-naive patients with first-episode psychosis: Haloperidol versus olanzapine.
Rasmussen SA; Rosebush PI; Anglin RE; Mazurek MF
Psychiatry Res; 2016 Jul; 241():72-7. PubMed ID: 27156027
[TBL] [Abstract][Full Text] [Related]
14. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial.
Revicki DA; Genduso LA; Hamilton SH; Ganoczy D; Beasley CM
Qual Life Res; 1999 Aug; 8(5):417-26. PubMed ID: 10474283
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A
Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
[TBL] [Abstract][Full Text] [Related]
17. Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial.
Perlis RH; Baker RW; Zarate CA; Brown EB; Schuh LM; Jamal HH; Tohen M
J Clin Psychiatry; 2006 Nov; 67(11):1747-53. PubMed ID: 17196055
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia.
Breier A; Hamilton SH
Biol Psychiatry; 1999 Feb; 45(4):403-11. PubMed ID: 10071708
[TBL] [Abstract][Full Text] [Related]
19. Placebo-controlled trials do not find association of olanzapine with exacerbation of bipolar mania.
Baker RW; Milton DR; Stauffer VL; Gelenberg A; Tohen M
J Affect Disord; 2003 Jan; 73(1-2):147-53. PubMed ID: 12507747
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
